BioSpace News Archive

Genetesis Announces Formal Publication of Results from the MAGNETO Trial

Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice.

April 2, 2024
·
3 min read
Business

Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board

Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Wendy Chung, M.D., Ph.D., has joined Sail’s Board of Directors.

April 2, 2024
·
2 min read
BioMidwest

EarliTec Diagnostics, Inc. Raises $21.5 Million in Series B Financing; Funds to Accelerate Commercialization of EarliPoint Evaluation and Further Product Development

EarliTec Diagnostics, Inc. announced today a $21.5 million Series B financing round, led by Nexus NeuroTech Ventures and Venture Investors Health Fund.

April 2, 2024
·
5 min read
Business

Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry

Odyssey Therapeutics, Inc. today announced the appointment of Julie Clauss, MBA, as chief operating officer and Christopher Butler, Ph.D., as senior vice president (SVP), head of Chemistry.

April 2, 2024
·
3 min read
Genetown

Juniper Biomedical Secures Seed Funding to Accelerate Growth and Innovation in Pelvic Health Disorders.

Juniper Biomedical announced today that it has successfully completed an oversubscribed $2M Series Seed financing and also has been awarded $1M through the NIH Common Fund as a winner of the NIH SPARC Neuromod Prize.

April 2, 2024
·
2 min read
BioCapital

Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses

Longhorn Vaccines and Diagnostics Congress all day April 2-4, 2024 on a mice study that examined LHNVD-110, a novel, unconjugated single peptide vaccine comprised of multiple epitopes to broadly target human and influenza viruses.

April 2, 2024
·
4 min read
Business

Oscar Health, Inc. 2024 First Quarter Conference Call

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.

April 2, 2024
·
1 min read
Biotech Bay

Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor

Glucotrack, Inc. and The Technology Partnership, announced the completion of computational modeling for Glucotrack’s implantable Continuous Blood Glucose Monitor, suggesting sensor longevity beyond three years, a year longer than the Company previously announced.

April 2, 2024
·
5 min read
BioMidwest

Bridge to Life Announces Abstract Presentations at The European Society for Transplantation’s ELITA Summit 2024 in Madrid, Spain, April 18-20, 2024

Bridge to Life Ltd, a renowned market leader in organ preservation solutions, today announced the presentation of two accepted abstracts at the 2024 ELITA Summit under the auspices of The European Society for Transplantation.

April 2, 2024
·
1 min read
IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with Cryoprobes

IceCure Medical Ltd. today announced it has filed a 510(k) submission with the United States Food and Drug Administration (“FDA”) for clearance of its next-generation single probe cryoablation system, the XSense™ System and cryoprobes.

April 2, 2024
·
4 min read